268 related articles for article (PubMed ID: 23600457)
1. The parkinson's disease-associated LRRK2 mutation R1441G inhibits neuronal differentiation of neural stem cells.
Bahnassawy L; Nicklas S; Palm T; Menzl I; Birzele F; Gillardon F; Schwamborn JC
Stem Cells Dev; 2013 Sep; 22(18):2487-96. PubMed ID: 23600457
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.
Cho HJ; Liu G; Jin SM; Parisiadou L; Xie C; Yu J; Sun L; Ma B; Ding J; Vancraenenbroeck R; Lobbestael E; Baekelandt V; Taymans JM; He P; Troncoso JC; Shen Y; Cai H
Hum Mol Genet; 2013 Feb; 22(3):608-20. PubMed ID: 23125283
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity.
Gillardon F; Schmid R; Draheim H
Neuroscience; 2012 Apr; 208():41-8. PubMed ID: 22342962
[TBL] [Abstract][Full Text] [Related]
4. Gene and MicroRNA transcriptome analysis of Parkinson's related LRRK2 mouse models.
Dorval V; Mandemakers W; Jolivette F; Coudert L; Mazroui R; De Strooper B; Hébert SS
PLoS One; 2014; 9(1):e85510. PubMed ID: 24427314
[TBL] [Abstract][Full Text] [Related]
5. Non-cell autonomous mechanism of Parkinson's disease pathology caused by G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis.
Kim J; Daadi MM
Brain Res; 2019 Nov; 1722():146342. PubMed ID: 31330122
[TBL] [Abstract][Full Text] [Related]
6. Enhanced dendritogenesis and axogenesis in hippocampal neuroblasts of LRRK2 knockout mice.
Paus M; Kohl Z; Ben Abdallah NM; Galter D; Gillardon F; Winkler J
Brain Res; 2013 Feb; 1497():85-100. PubMed ID: 23270607
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.
Verma M; Callio J; Otero PA; Sekler I; Wills ZP; Chu CT
J Neurosci; 2017 Nov; 37(46):11151-11165. PubMed ID: 29038245
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology changes associated with LRRK2 mutations in Parkinson's disease.
Lu YW; Tan EK
J Neurosci Res; 2008 Jul; 86(9):1895-901. PubMed ID: 18338801
[TBL] [Abstract][Full Text] [Related]
9. G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization.
Papkovskaia TD; Chau KY; Inesta-Vaquera F; Papkovsky DB; Healy DG; Nishio K; Staddon J; Duchen MR; Hardy J; Schapira AH; Cooper JM
Hum Mol Genet; 2012 Oct; 21(19):4201-13. PubMed ID: 22736029
[TBL] [Abstract][Full Text] [Related]
10. Progressive degeneration of human neural stem cells caused by pathogenic LRRK2.
Liu GH; Qu J; Suzuki K; Nivet E; Li M; Montserrat N; Yi F; Xu X; Ruiz S; Zhang W; Wagner U; Kim A; Ren B; Li Y; Goebl A; Kim J; Soligalla RD; Dubova I; Thompson J; Yates J; Esteban CR; Sancho-Martinez I; Izpisua Belmonte JC
Nature; 2012 Nov; 491(7425):603-7. PubMed ID: 23075850
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene.
Somme JH; Molano Salazar A; Gonzalez A; Tijero B; Berganzo K; Lezcano E; Fernandez Martinez M; Zarranz JJ; Gómez-Esteban JC
Parkinsonism Relat Disord; 2015 May; 21(5):494-9. PubMed ID: 25840672
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression.
Gehrke S; Imai Y; Sokol N; Lu B
Nature; 2010 Jul; 466(7306):637-41. PubMed ID: 20671708
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
[TBL] [Abstract][Full Text] [Related]
14. LRRK2 R1441G in Spanish patients with Parkinson's disease.
Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V
Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109
[TBL] [Abstract][Full Text] [Related]
15. Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death.
Angeles DC; Gan BH; Onstead L; Zhao Y; Lim KL; Dachsel J; Melrose H; Farrer M; Wszolek ZK; Dickson DW; Tan EK
Hum Mutat; 2011 Dec; 32(12):1390-7. PubMed ID: 21850687
[TBL] [Abstract][Full Text] [Related]
16. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
[TBL] [Abstract][Full Text] [Related]
17. Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity.
Shu Y; Ming J; Zhang P; Wang Q; Jiao F; Tian B
PLoS One; 2016; 11(3):e0149739. PubMed ID: 26930193
[TBL] [Abstract][Full Text] [Related]
18. Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models.
Li T; Yang D; Zhong S; Thomas JM; Xue F; Liu J; Kong L; Voulalas P; Hassan HE; Park JS; MacKerell AD; Smith WW
Hum Mol Genet; 2014 Dec; 23(23):6212-22. PubMed ID: 24993787
[TBL] [Abstract][Full Text] [Related]
19. 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening.
Lavalley NJ; Slone SR; Ding H; West AB; Yacoubian TA
Hum Mol Genet; 2016 Jan; 25(1):109-22. PubMed ID: 26546614
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 and mitochondria: Recent advances and current views.
Singh A; Zhi L; Zhang H
Brain Res; 2019 Jan; 1702():96-104. PubMed ID: 29894679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
